EP Patent

EP3355882A1 — Compositions comprising a statin for use in methods of adipolysis

Assigned to Kythera Biopharmaceuticals LLC · Expires 2018-08-08 · 8y expired

What this patent protects

Provided herein are pharmacologically active compositions suitable for topical application or injection directly for fat treatment without the need for surgical intervention.

USPTO Abstract

Provided herein are pharmacologically active compositions suitable for topical application or injection directly for fat treatment without the need for surgical intervention.

Drugs covered by this patent

Patent Metadata

Patent number
EP3355882A1
Jurisdiction
EP
Classification
—
Expires
2018-08-08
Drug substance claim
No
Drug product claim
No
Assignee
Kythera Biopharmaceuticals LLC
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.